About Ibnsina Pharma
Ibnsina Pharma is a publicly listed company based in Alexandria (Egypt) founded in 2001. Pharmaceutical products are distributed by Ibnsina Pharma. Ibnsina Pharma has completed 1 acquisition, including 3elagi. Its website ibnsina-pharma.com draws about 37 thousand monthly visits. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include MPIEGYPT and XpertsMed.
Company details
Ibnsina Pharma was founded in 2001 in Alexandria, Egypt, where operations are centered on pharmaceutical distribution. The company functions within the healthcare sector, handling wholesale supply of medicines and related products. Logistics and inventory management are managed to support regional healthcare providers. Services extend to ensuring product availability across Egypt, with the domain ibnsina-pharma.com maintained for business communications. Focus remains on efficient supply chain processes in the pharmaceutical industry.
- Headquarters Alexandria, Egypt
- Stage Public
- SectorsHealthcare
- Website ibnsina-pharma.com
- Social LinkedIn Facebook
- Legal Name Ibnsina Pharma
- Annual Revenue$76.6 B37.17as on Dec 31, 2025
- Net Profit$771.11 M54.9as on Dec 31, 2025
- EBITDA$3.95 B54.86as on Dec 31, 2025
- Latest Funding Round$27.55M (USD), Debt – Conventional
Jan 2026
- Investments & Acquisitions
Funding Insights of Ibnsina Pharma
- Total Rounds 1
- Last Round Debt – Conventional — $27.55M
- First Round $27.55M
(Jan 2026)
All 1 funding rounds of Ibnsina Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $27.55M | Debt – Conventional | – | – | – |
People of Ibnsina Pharma
40 people are tracked at Ibnsina Pharma (8 in leadership, 7 in board & advisors, 25 in team).
| Name | Role | Group |
|---|---|---|
Omar Abdel-Gawad | Co-CEO | Leadership |
Ahmed Refaat | HR Director | Leadership |
Mohsen Mahgoub | Vice Chairman & Managing Director | Leadership |
Mahmoud Abdel-Gawad | Co-CEO | Leadership |
Osama Omar | Business Support Director | Leadership |
Amro Khorshid | IT Director | Leadership |
Amr Ezz El-Din | Data Analysis Section Head | Leadership |
Ossama Saad | Master Data, Assets Control Section Head | Infor ERP (eam/m3) Key Business User | Leadership |
Abd El Raheem Fahmy | Board Member | Board & advisors |
Hany Bader | Board Member | Board & advisors |
Mohamed Mahgoub | Board Member | Board & advisors |
Abdel Aziz Ali | Chairman | Board & advisors |
Ahmed Al Nawawi | Board Member | Board & advisors |
Ahmed Abdel-Gawad | Board Member | Board & advisors |
Mohamed Abas | Board Member | Board & advisors |
Ali Hussein | Infor M3 Technical Team Lead | Team |
Hagar Ahmed | Senior Data Analyst | Team |
Mostafa Khattab | HR Generalist | Team |
Dr Yasser Elkott | Sales Manager | Team |
Saleh Mostafa | Group Total Rewards & HR Business Partnering Manager | Team |
20 more people are available in the full profile.
Complete people profiles for Ibnsina Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Ibnsina Pharma
Ibnsina Pharma is a publicly listed company on the EGX with ticker symbol ISPH in Egypt, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Dec 2017
- Listed onEGX: ISPH
- Listed entityIbnsina Pharma
- Exchange sectorDistribution services
- ISINEGS512O1C012
- Share price11.15 EGP (+1.36% on the day) · 2026-10-14
- Market capitalisation12,320,000,000.00 EGP
- Price to earnings15.8
- Dividend yield1.45%
- Volume (last session)1,206,994
Financials of Ibnsina Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 76.60B EGP | 771.1M EGP | 3.95B EGP |
| 2024 | 55.84B EGP | 497.8M EGP | 2.55B EGP |
| 2023 | 33.95B EGP | 173.1M EGP | 1.36B EGP |
| 2022 | 22.26B EGP | 132.2M EGP | 675.5M EGP |
| 2021 | 21.73B EGP | 286.3M EGP | 857.9M EGP |
Detailed financial statements for Ibnsina Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ibnsina Pharma
Ibnsina Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include 3elagi.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Prescription medicines and health products are ordered online through 3elagi. | 3elagi.com | Cairo, Egypt | 2017 | Nov 2020 | $1.59M |
Complete acquisition details for Ibnsina Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Ibnsina Pharma
4 dated milestones of Ibnsina Pharma across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Ibnsina Pharma is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires 3elagi.
- Funding First funding round of $27.6M.
Competitors of Ibnsina Pharma
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mpiegypt.com | 2005 | Cairo, Egypt | Distributes medical equipment, medications, and aesthetic products for healthcare and partnerships. | |||
| xpertsmed.com | 2017 | Cairo, Egypt | Provides high-quality medical devices and aesthetic solutions for healthcare. |
Detailed competitors of Ibnsina Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ibnsina Pharma
The website of Ibnsina Pharma (ibnsina-pharma.com) receives about 37.4K visits a month.
- Monthly visits37.4K
▲ 18.3% vs previous month
Websites whose visitors overlap most with Ibnsina Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mubasher.info | mubasher.info | 100% | #30,598 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ibnsina Pharma
Complete news archive for Ibnsina Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ibnsina Pharma
Ibnsina Pharma was founded in 2001 and raised its 1st funding round 25 years after it was founded.
Ibnsina Pharma is headquartered in Alexandria, Egypt.
Ibnsina Pharma was founded in 2001 in Alexandria, Egypt, where operations are centered on pharmaceutical distribution. The company functions within the healthcare sector, handling wholesale supply of medicines and related products. Logistics and inventory management are managed to support regional healthcare providers. Services extend to ensuring product availability across Egypt, with the domain ibnsina-pharma.com maintained for business communications. Focus remains on efficient supply chain processes in the pharmaceutical industry.
Yes, Ibnsina Pharma is publicly traded on EGX under the ticker symbol ISPH.
Ibnsina Pharma has made 1 acquisition, including 3elagi.